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correlated with RA disease activity indices such as C-reactive protein and erythrocyte sedimentation rate. Thus, shared and abnormally expanded EMT and Th17 TCR repertoires might be pivotal for RA pathogenesis.
Introduction:
Rheumatoid arthritis (RA) is a systemic immune disorder that mainly affects joints, causing chronic inflammatory damage with a high rate of disability; however, its etiology and underlying immunological mechanisms are still elusive. Disease modifying anti-rheumatic drugs (DMARDs) such as methotrexate have long been administered in clinical practice and are defined as first-line treatments according to the most recent guidelines 1 . However, these treatments can cause severe adverse effects due to their broad-range activities on the whole organism beyond the immune system.
To overcome the shortcomings of classical DMARDs and to pursue more precise treatment options, accumulating studies have demonstrated that T-cell-mediated immunity plays a pivotal role in the pathogenesis of RA, which could potentially be developed as a drug target 2 . Nevertheless, the efficacy of different T-cell-targeting therapies currently applied in clinical practice remains uncertain 3, 4 . Hence, a more thorough understanding of T cell biology in the setting of RA is urgently needed.
Based on basic T-cell biology, it is known that during the process of T-cell activation, CD4+ T cells recognize major histocompatibility complex-presented peptide fragments by expressing rearranged T-cell receptors (TCRs). Some evidence supporting a role for CD4+ T cells in RA pathogenesis is the association between this disease and HLA-DRB1, which encodes the polymorphic HLA class II DRβchain, and especially HLA-DR4 subtypes 5, 6 . The autoantigen-driven expansion of effector T-cell clonotypes is crucial for autoimmune inflammatory responses. Therefore, elucidating the TCR repertoire under conditions of autoimmunity could help to uncover the interaction between T-cells and pathogenic antigens in RA. Thereafter, studies utilizing similar PCR repertoire sequencing technology were performed. Two groups pointed out that TCRs might not accumulate clonally under certain circumstances 11, 12 . VanderBorght et al. found that T-cells expand oligoclonally in the synovium, but not in the peripheral blood 11 . Cantaert et al discovered that in anti-citrullinated protein antibody-positive (ACPA+) RA patients, similar preferential TCR clonal selection was observed, compared to that in ACPA− RA patients.
Notwithstanding these controversial findings, most studies have demonstrated that the T cells from RA patients respond through clonal expansion in the synovia and/or peripheral blood 11, 13, 14, 15, 16, 17, 18, 19, 20, 21 .
All of these early studies investigated TCR clonality at the pan-T-cell level and inevitably overlooked the differential functions of different subsets, due to limitations in basic techniques and the knowledge of T-cell biology. It is now certain that different T-cell subsets have very distinct roles in initiating and exacerbating the disease. Recent studies showed that some unique T-cell subpopulations, such as Th1 cells and IL-17 producing Th17 cells, are expanded during RA progression. Th1 cells produce interferon (IFN)-γ and tumor necrosis factor (TNF)-α, promoting inflammation in the synovia during RA 22, 23 . Further, the Th-17-IL-17-IL-23 axis was found to be crucial to trigger local inflammation and it also contributes to chronicity in murine models 24, 25 . Another important regulatory mechanism in RA involves CD4+CD25+ Treg cells, which help to maintain peripheral tolerance and protect against the initiation of autoimmune-mediated pathology 26 . Researchers believe that in this disease, there is an imbalance between Treg and Th17 cells, which leads to unresolved inflammation 27, 28 . In other human autoimmune disease studies, Th17 cells were suggested to interact or develop connections with various cell types including Treg, effector memory T cells (EMT), and dendritic cells, among others 29, 30, 31, 32 . However, how these T-cell subsets are derived and how their function is maintained are still unclear, and the aforementioned findings clarify the contention that both pre-existing cytokines and cell-cell interactions lead to disease chronicity.
As described, there is a missing link between T-cell subsets with distinct functions and their contribution to the pan-TCR repertoire. Accordingly, in the present study, we classified CD4+ T cells into naïve (NT), effector (ET), central memory (CMT), and EMT subsets according to antigen experience and cell development processes, in addition to Th1, Th17, and Treg cells, which have been suggested to be involved in the pathogenesis of RA. We utilized TCR repertoire sequencing technologies and bioinformatics strategies to quantitatively evaluate the TCR repertoires of these T-cell subsets from RA patients in an attempt to determine the origins of different subsets and provide clues for novel therapeutic strategies.
Results: Sample set
Peripheral blood mononuclear cells (PBMCs) from twelve RA patients and eight age-and gender-matched healthy controls (HCs) were isolated and sorted into seven clonotypes were generated from the data normalized to cell numbers.
Abnormal gene usage and CDR3 length in RA
The rearrangement of V-and J-gene segments determines the response of CDR3 to HLA complex and antigenic peptides 33 . To evaluate the differences in TRBV and TRBJ repertoires between RA and HC groups, we examined the distribution of TRBV and TRBJ segments of different CD4+ T cell subsets. Among them, NT, EMT, and Th17 subsets demonstrated consistent tendencies regarding the use of V3-1 and J2-7
segments. In RA patients, the use of the TRBJ2-7 gene family was significantly reduced in NT and EMT subsets, and a decreasing trend was observed in the Th17 subset, compared to those in HCs (Fig. 1a) . However, the TRBV3-1 gene was associated with higher use in the NT, EMT, and Th17 subsets (Fig. 1b) in RA patients compared to that in HCs. We also detected the decreased use of TRBV6-2 and TRBV6-3 in the NT subset, TRBV15 in the EMT subset, and TRBV7-9 in the Th17 subset (Fig. 1b) . Moreover, the use of TRBV3-1, TRBV6-1, TRBV6-2, TRBV6-3, and TRBV6-5 in CMT cells, TRBV24-1, TRBV28, and TRBV7-2 in ET cells, and TRBV12-4 in
Tregs was also significantly different in RA patients compared to that in HCs (Supplementary Figure S3) . Except for TRBJ2-7, no other J gene expression was significantly different in each subset, when comparing RA to HC groups (Supplementary Figure S4) .
A previous study on type 1 diabetes found that the length of the TCRB CDR3
was reduced in patients 34 , which resulted in the generation of an enriched repertoire of auto-reactive TCRs and susceptibility to disease pathogenesis. Thus, whether RA, as another typical autoimmune disease, is associated with this phenomenon was of profound interest. CDR3 length changes can be attributed to pre-selection, negative and positive selection in the thymus, antigen selection, or any combination. We therefore examined these processes in detail, by analyzing the length of unproductive (out-of-frame, OOF) TCRB CDR3 in NT cells and productive (in-frame)
TCRB CDR3 in different CD4+ T-cell subsets. We found that the OOF CDR3 length in NT cells was differentially distributed (p = 0.018) in RA patients compared to that in HCs (Supplementary Figure S5a) . However, the in-frame CDR3 length was similar between RA and HC groups for each CD4+ T-cell subset (Supplementary Figure S5b) .
As OOF CDR3 would not be affected by thymus selection and NT cells are independent of antigen selection, we concluded that the pre-selected TCR repertoire in RA was biased in CDR3 length, which might be related to RA pathogenesis.
TCRB repertoires of EMT and Th17 cells are clonally expanded in RA patients
Diversity is an effective measurement to assess the state of the immune system challenged by autoimmune disease, and TCRB diversity in memory T cells was previously reported to be reduced with RA 35, 36 . To specify the roles of different cell subsets and to systematically address the change in TCR repertoires in RA, the Shannon-index was used to examine the diversity of each subset, and normalized Diversity 20 (D20) and Diversity 50 (D50) indexes were also calculated to determine clonality. The Th17 subset from RA patients had a lower D20 index compared to that of HCs and the same tendency was observed for the D50 index, suggesting that Th17 cells in RA are more clonal ( Fig. 2a and Supplementary Figure S6 ). The EMT subset from RA had a significantly lower Shannon-index, indicative of less diversity, whereas diversity and clonality in CMT cells were similar between RA and HC groups ( Fig. 2a and b). Therefore, Th17 and EMT cells, rather than the other subsets, experienced significant clonal expansion in RA patients. As self-antigens are regarded as key factors in the induction of RA, antigen-specific expansion was expected in Th17 cells from RA patients. In addition, the tendency of decreased EMT diversity in RA patients suggested that these cells could also be influenced by auto-antigens.
TCRB repertoires of Th17 cells show an increased correlation with EMT cells in RA
TCRs, serving as the unique proxies of T-cells, can be used to track their development and differentiation 37 . As the repertoires of Th17 cells from RA patients exhibited a series of abnormal phenotypes including a higher proportion and increased clonality compared to those in HCs, we examined the correlation between TCRB repertories and Th17 and other subsets using overlapping indices. As shown in 
EMT cells in RA patients are inclined to differentiate into Th17 cells ex vivo
Th17 cells were found to be crucial for the development of RA; however, the sources and maintenance of specific antigen-expanded Th17 cells are still unclear.
Mounting studies support the plasticity of the Th17 lineage; meanwhile, researchers believe that committed Th17 cells can survive the contraction phase to form EMT cells 38, 39 . In addition to being differentiated from naïve T cells, Th17 cells can also proliferate and undergo self-renewal or can be induced by memory CD4+ T cells in vitro 40, 41 . As an increase in the overlapping indices between EMT and Th17 cells was identified in PBMCs from RA patients in this study, the differentiation from EMT to We then annotated the functions of CDR3 clonotypes from each sample based on the knowledge dataset (https://db.cngb.org/pird/tbadb/), which records disease-related sequences and information on these sequences. As shown in
Supplementary Figure S8 , T-cells in CMT subsets from RA patients included more pathogen-related clonotypes, suggesting that pathogens could trigger RA 42 . Due to the limited record of auto-antigen-related TCR sequences, the remaining clonotypes unique to RA patients could not be characterized based on a determined immunological explanation.
Discussion:
RA is a complex autoimmune disease with multiple etiological factors, among which, aberrant T-cell activation plays a key role in the initiation and perpetuation of the disease. In the present study, we focused on seven important CD4+ T-cell subsets, namely NT, ET, EMT, CMT, Th1, Th17, and Treg, considering both antigen experience during cell development processes and T-cell immune responses and regulation.
The biased use of the Vα-gene and Vβ-gene has been reported in T cells from synovial fluid; however, the significantly different use of any V-gene was not identified in the peripheral blood 21, 43, 44 . In this study, we found that the use of 11 V-genes and 1 J-gene by the TCRB was different in certain subsets between RA and HC groups. Notably, among them, we found that use of the V3-1 and J2-7 segments showed a similar trend for NT, EMT, and Th17 subsets. The abnormal use of these two genes has been observed in numerous autoimmune and infectious diseases. The TRBJ2-7 gene was found to be abnormally expressed in patients with systemic lupus erythematosus 45 , type 1 diabetes 46 , and chronic hepatitis B 47 . Alexandra et al.
reported that the TRBV3-1 gene was highly expressed in Th1 and Th17 cells of primary Sjögren's syndrome patients 48 . Further, the abnormal expression of TRBV3-1 and TRBJ2-7 might be associated with the pathogenesis of immune-related diseases.
V/J gene use in healthy individuals was suggested to be mostly influenced by HLA 49 , but the antigen-driven effect should not be ignored 50, 51 . Commonalities in the usage bias of TRBV3-1/TRBJ2-7 in NT, EMT, and Th17 cells suggested a stronger correlation between these subsets. Further work is needed to explore this relationship. Our study also indicated that the OOF CDR3 length in NT cells was reduced in RA patients,
suggesting that early events during T cell development and the re-arrangement of the TCR in RA might be abnormal. We speculate that the auto-reactive TCR repertoire was probably generated during biased early V(D)J gene recombination and that this pre-selected repertoire might contribute to RA susceptibility.
Studies have reported that TCR repertoire diversity is decreased in RA and other autoimmune diseases due to the specific autoantigen-derived amplification of T cell clonality. In this study, we highlighted the decreased diversity and increased clonality of TRB CDR3 in Th17 and EMT cells based on Shannon-index and D20 index analysis, indicating a high frequency of clonal amplification these subsets. Furthermore, we found correlations between different subsets, especially Th17 and EMT cells, in RA and HC groups, which could reflect a common source of these amplified clonotypes. In summary, through analyzing the TCR repertoire of different CD4+T cell subsets in RA patients, we detected the abnormal expression of TRBV3-1 and TRBJ2-7
segments. This loss of diversity in RA patients was mainly found to exist in Th17 and EMT subsets. More importantly, we identified a correlation between Th17 and EMT subsets and the differentiation from EMT cells to Th17 cells in RA patients, which might play a key role in RA pathogenesis.
Methods:
Patients and controls were recorded. Disease activity was measured using the DAS28 calculated by CRP (DAS28-CRP). The clinical features of all patients are presented in Supplementary   Table S2 . 
Sample collection and fluorescence-activated cell sorting (FACS) analysis

TCRB repertoire sequencing library construction and sequencing
RNA was isolated from sorted cells using Trizol (Invitrogen) as indicated by the manufacturer's guidelines. Entire samples of isolated RNA were used to synthesize cDNA, and then the CDR3 regions of the TCRB were enriched by multiplex PCR and sequenced as previously described 59 . In brief, gDNA was removed from RNA samples with DNase I digestion (NEB) for 10 min at 37 C. Then cDNA was synthesized from purified RNA using SuperScript I reverse transcriptase (Invitrogen) with a primer specific to the TCRB constant region (5′-CACGTGGTCGGGGWAGAAGC-3′). cDNA was used as the template for multiplex PCR to enrich the target regions of CDR3s with a pool of 30 TRBV primers and 13 TRBJ reverse primers. After PCR, the cDNA with a band size of 110-180 bp was extracted from the 2% agarose gel and purified.
Paired-end 150-bp sequencing was then performed using the Hiseq 4000 system (Illumina) following the instructions of the manufacturer.
Alignment and data analysis
Raw sequencing data were analyzed using IMonitor 60 , which included four main steps for alignment and error correction. First, basic quality control was performed to filter out the low-quality reads and then the clean paired-end reads were merged. Second, two-step BLAST alignment was performed on these merged data according to the Figure S9) . The diversity and clonality of samples were evaluated based on the Shannon-index, D20 index, and D50 index. With normalized reads, the Shannon-index was calculated as follows:
where S is the sum of unique CDR3.AA sequences, which is regarded as a clonotype and p(i) indicates the frequency of the ith clonotype. D20 and D50 represent the percentage of dominant unique clonotypes accounting for 20% and 50% of the total CDR3.AA sequences in a given sample, respectively; the D20 and D50 values were normalized to the total number of clonotypes 61 .
Overlap indices
Jaccard indices were used to quantify shared clonotypes between two samples from different subsets from one donor as follows:
S1 is the sum of number of overlaps; the ith overlapping clonotype might have different numbers of sequences for each sample; count(min)(i) refers to the smaller value; S2 and S3 represent the sum of the number of clonotypes within each sample, respectively.
Motif analysis of CDR3s amino acids
Motif analysis was calculated using MEME suite 5.0.3 (http://meme-suite.org/) 62 .
Statistics
In-house R scripts and GraphPad Prism were employed for this study. To compare the differences between two groups, the two-tailed student's t-test or two-tailed Mann-Whitney U-test was used. The Spearman method was used to calculate correlations and the χ 2 -test was used to determine the length distribution statistic of overlapping clonotypes. P values < 0.05 were considered significant.
Data availability
The sequence data that support the findings of this study have been deposited in the China Nucleotide Sequence Archive (CNSA) with the primary accession code CNP0000357. NT, naïve T cells; EMT, effector memory T cells. Spearman's correlation).
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